Hatswell AJ - Search Results

1

Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.

Elvidge J, Bullement A, Hatswell AJ. Elvidge J, et al. Among authors: hatswell aj. Pharmacoeconomics. 2016 Nov;34(11):1145-1159. doi: 10.1007/s40273-016-0423-y. Pharmacoeconomics. 2016. PMID: 27318837

2

Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL).

Bloor A, De Cock E, Hatswell AJ, Wasiak R, Elvidge J, Stapelkamp C, Hadjivassileva T, Haiderali A, Delgado J. Bloor A, et al. Among authors: hatswell aj. Br J Haematol. 2015 May;169(3):449-52. doi: 10.1111/bjh.13224. Epub 2014 Nov 20. Br J Haematol. 2015. PMID: 25410960 Free article. No abstract available.

3

The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's Lymphoma.

Muszbek N, Kadambi A, Lanitis T, Hatswell AJ, Patel D, Wang L, Singer JW, Pettengell R. Muszbek N, et al. Among authors: hatswell aj. Clin Ther. 2016 Mar;38(3):503-15. doi: 10.1016/j.clinthera.2016.01.004. Epub 2016 Feb 5. Clin Ther. 2016. PMID: 26856929 Free article. Clinical Trial.

4

Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.

Hatswell AJ, Freemantle N, Baio G. Hatswell AJ, et al. Pharmacoeconomics. 2017 Feb;35(2):163-176. doi: 10.1007/s40273-016-0460-6. Pharmacoeconomics. 2017. PMID: 27778240 Review.

5

The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight.

Hatswell AJ, Porter J, Lee D, Hertel N, Latimer NR. Hatswell AJ, et al. Value Health. 2016 Dec;19(8):1055-1058. doi: 10.1016/j.jval.2016.04.013. Epub 2016 Jun 9. Value Health. 2016. PMID: 27987632 Free article.

6

Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis.

van der Nelson HA, Draycott T, Siassakos D, Yau CWH, Hatswell AJ. van der Nelson HA, et al. Among authors: hatswell aj. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:286-291. doi: 10.1016/j.ejogrb.2017.01.004. Epub 2017 Jan 3. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28088109

7

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Hatswell AJ, Chandler F. Hatswell AJ, et al. Pharmacoeconomics. 2017 Aug;35(8):755-757. doi: 10.1007/s40273-017-0516-2. Pharmacoeconomics. 2017. PMID: 28528523 No abstract available.

8

Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales.

Bullement A, Underhill S, Fougeray R, Hatswell AJ. Bullement A, et al. Among authors: hatswell aj. Clin Colorectal Cancer. 2018 Mar;17(1):e143-e151. doi: 10.1016/j.clcc.2017.09.001. Epub 2017 Sep 28. Clin Colorectal Cancer. 2018. PMID: 29110922 Free article.

9

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

Pennington B, Marriott ER, Lichtlen P, Akbar A, Hatswell AJ. Pennington B, et al. Among authors: hatswell aj. Pharmacoecon Open. 2018 Sep;2(3):241-253. doi: 10.1007/s41669-017-0065-9. Pharmacoecon Open. 2018. PMID: 29302926 Free PMC article.

10

Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models.

Hatswell AJ, Bullement A, Briggs A, Paulden M, Stevenson MD. Hatswell AJ, et al. Pharmacoeconomics. 2018 Dec;36(12):1421-1426. doi: 10.1007/s40273-018-0697-3. Pharmacoeconomics. 2018. PMID: 30051268 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters